Critically ill COVID-19 patients first exhibit high D-dimer values, which are then followed by an increase in partial thromboplastin times, aberrant prothrombin levels, and lastly low platelet counts (Connors and Levy, 2020). This evidence concerns the gene F2 and COVID-19.